Iwasa Z, Matsunami N, Saeki Y, Kurooka K, Yamato M, Okuno K, Sagara N, Matsuda T, Yasutomi M
First Department of Surgery, Kinki University School of Medicine, Osaka, Japan.
Jpn J Surg. 1988 Mar;18(2):131-5. doi: 10.1007/BF02471420.
Preoperative intra-arterial infusion neo-adjuvant chemotherapy, in combination with local vein blocking, was administered to thirty-one patients with locally advanced stage III breast cancer. The anti-cancer drugs and dosages used were 500 mg of 5-Fluorouracil (5FU), which was infused daily for 7-14 days, and 20 mg of Adriamycin (ADM), which was administered as a bolus dose twice into the subclavian and internal mammary arteries. The response rate of this method on the primary tumor was 48.4 per cent, and, histologically it was found to be as high as 90.3 per cent. The response rate of the clinical effects on the regional lymph nodes was 50.0 per cent, however, histologically, it was found to be lower than that of the primary tumor. In the long-term follow-up study the 5-year survival rate was 72.2 per cent. Thus, this method seems to be effective as a combined modality in cases of locally advanced stage III breast cancer.
对31例局部晚期III期乳腺癌患者进行术前动脉内灌注新辅助化疗,并结合局部静脉阻断。使用的抗癌药物及剂量为:5-氟尿嘧啶(5FU)500mg,每日输注,持续7 - 14天;阿霉素(ADM)20mg,分两次大剂量注入锁骨下动脉和胸廓内动脉。该方法对原发肿瘤的有效率为48.4%,组织学有效率高达90.3%。对区域淋巴结临床疗效的有效率为50.0%,但组织学有效率低于原发肿瘤。在长期随访研究中,5年生存率为72.2%。因此,该方法作为局部晚期III期乳腺癌的联合治疗方式似乎是有效的。